A Case Report and Review of the Infant, Pediatric, and Adult Literature
To the Editor:
W e have had recent cause to review this article 1 and have noted some discrepancies in the way that some of the diphenhydramine blood levels were reported.
In Table 2 , the blood level of diphenhydramine is listed as 0.87 mg/100 mL and 0.69 mg/100 mL for case 13 and case 14 respectively. In Table 3 , the lowest value in the range of blood diphenhydramine levels is listed as 0.087 mg/L and 0.069 mg/L for adults and children respectively. In Table 6 , the lowest value in the range of blood diphenhydramine levels is listed as 0.87 mg/L and 0.69 mg/L for adults and children respectively.
In the article by Shkrum et al, 2 the primary reference for cases 13 and 14, blood diphenhydramine levels of 0.87 mg/100 mL and 0.69 mg/100 mL are reported for a 25year-old male and a 17-year-old female respectively. The level reported in Table 6 and Table 3 appear to be inaccurate by a factors of 10 and 100 respectively, compared with the levels reported in the primary reference.
This highlights common mistakes that can be made when communicating, reporting or abstracting levels of any drug.
Urgency of Suicide Prevention Measures for Older Women in Japan
T he National Police Agency recently reported 32,155 annual suicides in Japan for 2006; annual suicides, which exceeded 30,000 annually after 1998. Based on the current state of suicide in Japan since 1998, most suicide researchers in Japan are studying the problems of suicide because of financial reasons or unemployment and suicide related to overwork, both of which mainly involve middle-aged men, with an eye toward preventing these suicides in terms of industrial, community, and psychiatric medicine. 1, 2 Nevertheless, worldwide study of suicides in Japan raises the question of whether taking measures to prevent suicides for middle-aged men alone will be linked to a decline in suicides. Thus, in this study we studied the suicide mortality rate by sex in Japan and several other regions based on the collected data of the World Health Statistics Annual, Vital Statistics, and discussion reports etc. 3, 4 With regard to the suicide mortality rate by age group, we studied the suicide rate by age group for women in Mie Prefecture, which represented the median of Japan's suicide rates as revealed when Yoshioka reported on a large-scale study of Japan's suicides, from 1990 to 2002 with the cooperation of the Mie Prefectural Police Headquarters. 5 Worldwide, Japan ranked 10th for male suicides and third for female suicides, indicating Japan has suicide mortality rates for both men and women, so women in particular have a high suicide mortality rate in comparison to the rest of the world.
Older women in particular had high suicide mortality rates, with those ages 80 and over ranking number 1 and those ages 70 to 79 ranking number 2.
According to Yoshioka's report, 3 the context for suicide by older age groups in Japan most often involves, for both sexes, suicide because one is "suffering from physical illness." That is, suicides by older women are among an age group to which attention must be paid when studying Japan's suicide mortality rate, and attention must be directed toward those "suffering from physical illness" in particular.
Doctors, nurses, and other personnel must pay attention to whether they sense, even if only slightly, that older women who are visiting the facility because of "physical illness" are having suicidal thoughts and when they sense, even if only slightly, such women are having suicidal thoughts, this recognition must be promptly linked to treatment, eg, referral to a specialist like a psychiatrist. In addition, family residing with or in contact with older women must, if they sense the woman is having suicidal thoughts, recognize variations in symptoms so that this recognition is promptly linked to treatment at a medical facility. Further liason between the community, residents, welfare bodies, administrative bodies, and the medical establishment should take place to decrease the suicide rate of older women.
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